Mark L. Day
0000-0001-7774-2326
Publication & Citation Trends
Publications
0 total
Differentiating bladder cancer (BLCA) tumor immune microenvironment (TME) profiles based on predicted intrinsic radiosensitivity (RS).
Cited by 0
Semantic Scholar
Quantification and immunoprofiling of bladder cancer cell-derived extracellular vesicles with microfluidic chemiluminescent ELISA OA
Cited by 12
Semantic Scholar
Abstract 1194: MEK inhibition in combination with PI3K/AKT/MTOR is a promising therapeutic in basal bladder cancer
Cited by 0
Semantic Scholar
Identification of Putative Gene-Target Modulators of Radiosensitivity in Bladder Cancer Cell Lines (BlaCCL). OA
Cited by 0
Semantic Scholar
MEK is a promising target in the basal subtype of bladder cancer OA
Cited by 8
Semantic Scholar
Abstract B35: Isolation and characterization of circulating tumor cells (CTCs) from bladder cancer patients using a highly sensitive graphene oxide-based microfluidic device (GO chip)
Cited by 1
Semantic Scholar
Transcriptomic and Mutational Analyses Identify Biological Processes Correlated with Bladder Cancer Cell Line (BlaCCL) Radiation Response OA
Cited by 0
Semantic Scholar
Abstract A16: Characterization of ErbB family expression in intratibial bladder cancer xenografts: Considerations for preclinical modeling
Cited by 0
Semantic Scholar
Research Topics
Bladder and Urothelial Cancer Treatments
(25)
Prostate Cancer Treatment and Research
(25)
HER2/EGFR in Cancer Research
(25)
Neuroscience and Neuropharmacology Research
(19)
Peptidase Inhibition and Analysis
(18)
Affiliations
Bryn Mawr College
Fauna and Flora International
Monsanto (United States)
IBM (United States)
Royal Society for the Protection of Birds